Integer Holdings Corporation
ITGR
Κατάταξη σε μετοχές
#3849
Integer Holdings Corporation functions as a global leader in outsourced medical... Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Τιμή μετοχής
$126.73
Τελευταίος συγχρονισμός: 2026-10-20
Κεφαλαιοποίηση
$4.31B
Αλλαγή (1 ημέρα)
-0.02%
Αλλαγή (1 έτος)
17.41%
Χώρα
US
Εμπόριο Integer Holdings Corporation (ITGR)
Κατηγορία
Healthcare
Έσοδα για την Integer Holdings Corporation (ITGR)
Έσοδα τον Jul 2026 TTM: $1.84B
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Integer Holdings Corporation, τα τρέχοντα έσοδα της εταιρείας (TTM) είναι $1.84B. Το 2023, η εταιρεία είχε έσοδα $1.56B αύξηση σε σχέση με τα έσοδα του έτους 2022, τα οποία ήταν $1.33B. Τα έσοδα είναι το συνολικό ποσό που παράγει μια εταιρεία από τις πωλήσεις προϊόντων ή υπηρεσιών. Σε αντίθεση με τα κέρδη, δεν αφαιρούνται έξοδα.
Ιστορικό εσόδων για την Integer Holdings Corporation από 2000 έως 2026
Έσοδα στο τέλος κάθε έτους
| Έτος | Έσοδα | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $1.84B | 7.26% |
| 2024 | $1.72B | 10.35% |
| 2023 | $1.56B | 16.85% |
| 2022 | $1.33B | 9.02% |
| 2021 | $1.22B | 13.75% |
| 2020 | $1.07B | -14.68% |
| 2019 | $1.26B | 3.55% |
| 2018 | $1.22B | 6.95% |
| 2017 | $1.14B | 5.63% |
| 2016 | $1.08B | 34.37% |
| 2015 | $800.41M | 16.38% |
| 2014 | $687.79M | 3.59% |
| 2013 | $663.95M | 2.75% |
| 2012 | $646.18M | 13.60% |
| 2011 | $568.82M | 6.64% |
| 2010 | $533.43M | 2.22% |
| 2009 | $521.82M | -4.54% |
| 2008 | $546.64M | 71.50% |
| 2007 | $318.75M | 17.56% |
| 2006 | $271.14M | 12.46% |
| 2005 | $241.10M | 20.48% |
| 2004 | $200.12M | -7.51% |
| 2003 | $216.37M | 29.33% |
| 2002 | $167.30M | 23.40% |
| 2001 | $135.58M | 38.64% |
| 2000 | $97.79M | 0.00% |
Έσοδα για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Έσοδα | Διαφορά Εσόδων | Χώρα |
|---|---|---|---|
| $46.59B | 2,430.20% |
US
|
|
| $35.48B | 1,827.27% |
IE
|
|
| $25.84B | 1,303.30% |
US
|
|
| $21.00B | 1,040.37% |
US
|
|
| - | - |
DE
|
